What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Kaia Health Lands $26M to Expand AI-Driven Digital Therapeutics for MSK Conditions & COPD
What You Should Know:
- Digital therapeutics company Kaia Health raises $26M in
Series B funding to help grow its digital therapy solutions for musculoskeletal
(MSK) conditions, and expand into new conditions.
- The investment was led by Optum Ventures, Idinvest and
capital300, plus participation from Balderton Capital, Heartcore Capital and
Symphony Ventures, an investment partnership with world #1 golfer Rory McIlroy.
- Kaia Health’s smartphone-based
approach to managing chronic
Read More
MD Anderson, Philips Partner on Personalized Oncology Treatments, Clinical Trial Matching
What You Should Know:
- Philips and MD Anderson collaborate to facilitate
personalized oncology treatments and clinical trial matching based on genomic
markers.
- Philips connects oncologists and pathologists around
the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of
actionable clinical information
Philips and The University of Texas MD Anderson Cancer
Center today announced a collaboration to provide oncologists with
evidence-based therapy and clinical
Read More
How A Virtual Therapist Could Help Overcome Mental Healthcare Demands in Uncertain Times
Over the last few months, our hopes and expectations for 2020 have certainly been halted. There was an air of optimism globally as we entered the New Year and a new decade, but now we have been plunged into a world of uncertainty with the spreading COVID-19 pandemic. Future unknowns, both from a human well-being perspective and an economic standpoint are starting to take a toll on many people’s mental health.
Understandably, the situation we find ourselves in is creating concern and worry and
Read More
COVID-19 Clinical Trials: How AI-Based Chatbots Can Provide Pandemic-Level Execution
More than 500 new COVID-19 related clinical trials have been registered as of the end of April. The race to find a COVID-19 vaccine is on and the public spotlight is on clinical trials. Strangely named drugs such as Hydroxychloroquine and Remdesivir have become household names and are featured and debated regularly on the 24-hour news channels.
The pressure to find a cure is intense. The locked-down world does not want to hear that at best, we may find a vaccine sometime in 2021. What
Read More
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know:
- Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
- Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine.
Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
Net Health Acquires Wound Care Platform Tissue Analytics
What You Should Know:
- Net Health acquires wound care platform Tissue Analytics to expand Net Health’s leadership position in the wound care market.
- Tissue Analytics, Inc. deploys its wound management software via industry-leading SMART on FHIR integrations with Epic, Cerner, Allscripts, and others.
- Net Health plans to integrate Tissue Analytics app will be integrated with their WoundExpert EHR solution to add key capabilities for use within hospital outpatient
Read More
Medable Lands $25M to Expand Platform for Decentralized Clinical Trials
What You Should Know:
- Medable raises $25M in funding to expand global platform for decentralized clinical trials led by GSR Ventures, with additional investment from existing investor PPD, Inc.
- Founded in 2015, Medable’s global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution.
Medable, Inc., a Palo
Alto, CA-based global platform for
Read More
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment.
AiCure,
Read More
Healthcare Data Platform H1 Raises $12.9M to Fuel Growth
What You Should Know:
- H1, the biggest database in the world connecting healthcare, life science professionals, and companies raises $12.9M in funding.
- Its healthcare data platform provides comprehensive in-depth profiles of more than 8 million healthcare professionals and 16,000 institutions in 70+ countries, all of which are kept up-to-date weekly. The platform enables users to understand and analyze any healthcare professional’s full profile, including expertise, interests,
Read More